There is no warning in the Elekta Unity manual for the administration of gadolinium-based or other contrast agents for imaging or image guidance purposes has not been validated.
Source facts
Action
Elekta notified customers on about 04/03/2019 via email with "URGENT IMPORTANT FIELD SAFETY NOTIFICATION" letter. Instructions included to ensure all staff working with Elekta Unity are aware of the issue and recall information and post the recall notice in a place accessible to all users, e.g. Instructions for use, until the recall is closed. Additionally customer were asked to complete and return the Acknowledgement Form.
Initiated
2019-04-03
Root cause
Labeling design
Terminated
2023-05-01
Distribution
Worldwide Distribution - US Nationwide in the states of Texas and Wisconsin.
Distribution internationally to Denmark, England, Germany, Italy, Netherlands
Recall number
Z-1297-2019
Recall status
Terminated
CDRH record ID
171792
FDA classified
2019-05-08
Recall event number
82537
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.